Statistics on Biotechnology Use Results by fields of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.198 760 358 80 %Companies according to biotechnology used: Genetic code 33,3 42 15,5 30,8 %Companies according to biotechnology used: Functional units 39,8 43,9 35,3 21,6 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 24,2 28,2 15,1 26,7 %Companies according to biotechnology used: Bioprocesses 49,6 39,7 75,1 30,3 %Companies according to biotechnology used: Sub-cellular organisms 6,7 9,1 2,9 0 %Companies according to biotechnology used: Bio-computing 23,9 32,4 8,9 9,8 %Companies according to biotechnology used: Nanobiotechnology 11,2 14,3 6,3 2,8 %Companies according to biotechnology used: Other 14,6 14,7 10,2 33,8 Companies in which biotechnology activities are: Main and/or exclusive 644 522 102 19 Companies in which biotechnology activities are: A secondary line of business 171 93 64 14 Companies in which biotechnology activities are: A tool necessary for production 383 145 192 46 %Company by field(s) of ultimate application of biotechnology use: Human Health 47,3 61,9 25,9 4,8 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19,4 21,2 12,8 31,6 %Company by field(s) of ultimate application of biotechnology use: Food products 32,5 25,9 48,4 24,3 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24,1 22,6 18,8 63,1 %Company by field(s) of ultimate application of biotechnology use: Environment 14,9 15,3 14,7 12,4 %Company by field(s) of ultimate application of biotechnology use: Industry 12,8 14 12,3 3,8 Personnel in R&D in biotechnology (no. of persons) 13.615 8.885 3.811 919 Personnel in R&D in biotechnology (no. of persons): Researchers 7.436 5.473 1.733 231 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 6.178 3.412 2.078 688 Personnel in R&D in biotechnology (no. of persons): women 7.639 5.204 2.016 420 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 4.095 3.058 918 120 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.544 2.146 1.098 300 Personnel in R&D in biotechnology (FTE) 9.365,2 6.336,7 2.503,3 525,3 Personnel in R&D in biotechnology (FTE): Researchers 5.410,6 4.035,2 1.213,7 161,6 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.954,6 2.301,4 1.289,6 363,7 Personnel in R&D in biotechnology (FTE): women 5.385,8 3.708,1 1.422,7 254,9 Personnel in R&D in biotechnology (FTE): (women) Researchers 3.032,9 2.267,1 681,8 84 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.352,9 1.441 741 170,9 Internal expenditure on R&D (thousands of euros) 940.230 640.141 263.135 36.954 1) By nature of the expense: Current expenses 871.813 593.046 244.592 34.175 1.1) Remuneration to researchers 284.936 194.991 82.018 7.927 1.2) Remuneration to technicians and assistants 148.254 76.812 61.300 10.143 1.3) Other current expenses 438.623 321.243 101.274 16.105 2) By nature of the expense: Capital expenses 68.417 47.095 18.543 2.779 2.1) Land and buildings 11.763 7.319 2.786 1.659 2.2) Equipment and instruments 39.641 23.874 14.738 1.028 2.3) Acquisition of specific R&D software 2.831 2.597 151 83 2.4) Otros productos de propiedad intelectual específicos para I+D 14.183 13.305 868 10 1.1) By origin of the funds: Own funds 577.287 340.644 203.482 33.161 1.2) By origin of the funds: From companies 142.672 134.119 8.553 0 1.3) By origin of the funds: Public Administration funds 102.630 91.765 9.516 1.350 1.4) By origin of the funds: From Universities 457 453 5 0 1.5) By origin of the funds: From non profit private institutions 9.631 9.631 0 0 1.6) By origin of the funds: Foreign funds 107.553 63.529 41.580 2.444 Purchase of R&D services in biotechnology (thousands of euros) 114.839 57.515 56.730 594 Purchase of R&D services in biotechnology (thousands of euros): In Spain 69.258 21.868 46.928 462 Purchase of R&D services in biotechnology (thousands of euros): Abroad 45.581 35.647 9.802 132 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 41,8 51,5 24,9 25,4 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12 10,6 13,6 17,8 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 13,1 13,5 12,3 12,7 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,7 12,6 7,6 6,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 15,1 18,4 8,8 12,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 15,7 20,4 6,9 10,2 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 15,9 17,2 12,9 16,1 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 40 33 30 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 50,7 55,3 40,9 51,3 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 18,9 18 24,1 % Companies that have requested biotechnology patents in Biotechnology 18,3 22,8 11,5 6 Number of patents requested 643 513 108 22 % Companies with income of an international origin related to biotechnological activities 24,4 27 22,1 9,5 % Turnover representing income of an international origin related to biotechnological activities 1,6 5,8 1,3 1,6 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 55,7 30,6 63,4 70,6 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 44,3 69,4 36,6 29,4 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 70,3 94,8 62 98,7 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 23,9 0,4 31,7 1,3 % Income of an international origin related with activities according to the classification: Operating source abroad 5,3 2,4 6,3 0 % Income of an international origin related with activities according to the classification: Other 0,6 2,4 0 0 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute